MitraBiotech - for website

Mitra Biotec

Lead Partner

Mitra Biotech is a global leader in empowering oncology drug development. Our unique human ex vivo histoculture platform (CANscript™) characterizes human tumors that have been cultured in a fully recapitulated tumor microenvironment. The CANscript™  platform conserves tumor architecture and microenvironment and can be used to predict therapeutic response to a specific drug combination, as well as understand the mechanism of action of a given modality. Founded in 2010, Mitra Biotech is headquartered in the Boston area and maintains a significant research and laboratory presence in Bangalore, India.